# Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)

> **NCT04261582** · — · SUSPENDED · sponsor: **National Jewish Health** · enrollment: 245 (estimated)

## Conditions studied

- Aspirin Exacerbated Respiratory Disease
- Aspirin-Sensitive Asthma
- Nasal Polyps

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04261582
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-11-06
- **Primary completion:** 2022-04
- **Final completion:** 2022-04
- **Target enrollment:** 245 (ESTIMATED)
- **Why stopped:** On hold due to COVID-19 outbreak
- **Last updated:** 2021-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04261582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04261582, "Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04261582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*